Phibro Animal Health Corporation (PAHC) Q4 FY25 Earnings Call

Fiscal 2026 guidance targets approximately 25% adjusted EBITDA growth, including a full 12 months of the MFA portfolio [35][32].

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2025-08-28
Length31 minutes
EPS$0.57
EPS consensus$0.52
Revenue$378.7M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26

All PAHC earnings ยท Back to PAHC overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.